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April 20101070 Abstractsclaudication or chronic limb ischemia (CLI). Patients were monitored
clinically and with noninvasive laboratory testing for 30 months. Primary,
primary-assisted, and secondary patency and limb salvage were the primary
end points. Lesion location and length were evaluated for both groups.
Statistical analysis was performed using Kaplan-Meier and log-rank tests.
Results: Between 2004 and 2009, 984 lesions were analyzed in 407
patients (172 women and 235 men), of which 511 lesions were treated with
primary PTA and 473 were treated with PTAStent. There was no statistical
difference between the lesion distribution and characteristics of the PTA-
alone and PTAStent groups based on gender. The primary, primary-
assisted, secondary patency, and limb salvage in women treated with PTA
alone was significantly improved (P  .005) at all time points compared
with men undergoing PTA alone (Table). Outcomes after PTAStent for
men and women were similar for primary, primary-assisted, and secondary
patency at all intervals. Men had an improvement when PTAStent was
compared with PTA alone at all time intervals and patencies (P  .05).
There was also a statistically significant advantage for limb salvage in women
treated with PTA compared with men.
Conclusions: Women have significantly improved primary, primary-
assisted, secondary patency, and limb salvage rates compared with men after
treatment with PTA, and this should be the primary endovascular treatment
option for women; however, men may be better managed with primary
PTAStent. Table.
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Objective: The utility of duplex surveillance of arterial stents has been
controversial, primarily aimed at detecting in-stent restenosis. Although veloc-
ities are commonly reported, they do not represent blood flow. The patency of
arterial prostheses is flow-dependant. We performed a preliminary evaluation of
consecutive patients to determine if postprocedural duplex-calculated blood
flows through stents correlate with 12-month primary patency.
Methods: Consecutive patients undergoing arterial stent placement
were retrospectively reviewed. Information regarding demographics, co-
morbidities, stent size, postprocedural duplex information, and 12-month
patency were recorded. Blood flow was calculated using duplex velocities
and stent dimensions.
Results: The study comprised 27 consecutive patients (age, 72.6 14
years, 14 men) with 35 stents (18 iliofemoral, 10 carotid, and 7 subclavian/Fig.mesenteric). Mean time from the procedure to the duplex study was 47 days.
At 12 months, 20 stents were primarily patent (PP) and 15 were secondarily
patent (SP). There was a significant difference between the PP and SP groups
with respect to initial in-stent mean velocities (92.5 cm/s PP vs 43.7 cm/s
SP, P .002;) and calculated flows (1918 mL/min PP vs 722 mL/min SP,
P .0001).With these threshold values, calculated flows had corresponding
sensitivity, specificity, and accuracy of 92%, 82%, and 86.2%, respectively, for
predicting stent patency, whereas those for velocity measurements were
lower at 83%, 71%, and 76%, respectively. Receiver operating characteristic
(ROC) curve (Fig) analysis showed a significantly greater area under the
curve for calculated flows compared with velocity measurements (0.965 vs
0.859, P  .001).
Conclusions: Calculated blood flows from an initial postprocedural
duplex study accurately correlate to stent patency at 12 months. By ROC
analysis, velocities alone were less sensitive, less specific, and less accurate.
This preliminary findingmandates prospective analysis of this technique with
individual vascular beds and larger patient populations. A clinical protocol
guiding stent surveillance and decisions for early reintervention is suggested.
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Objective: Subintimal recanalization for the treatment of chronic total
occlusions (CTO) occasionally requires re-entry devices to access the true
lumen distally. Limited information is available on factors predicting the
success or failure of these devices.
Methods: All CTO cases from August 2006 to August 2009 were
retrospectively reviewed. Age, gender, occlusion length, site of re-entry, and
the angle of the aortic bifurcation were recorded. A calcification score (none,
mild, moderate, severe) at the re-entry site was assigned based on procedural
angiograms. Univariate and multivariate logistic regression analyses were
used to identify factors predicting failure of re-entry into the true lumen. The
Outback LTD re-entry device (Cordis) was used in all cases.
Results: Of 249 CTOs treated, the re-entry device was used 52 times
(20.9%), comprising 47 superficial femoral artery (SFA) occlusions and 5
combined SFA and popliteal artery occlusions (33 TransAtlantic Intersociety
Consensus II type C and 18 type D lesions). Of 48 procedures with available
angiograms for review, the target re-entry site was at the adductor canal in 30
(62.5%), the above-knee popliteal artery in 13 (27.1%), the behind the knee
joint in 4 (8.3%), and the mid-SFA in 2 (4.2%). The mean age was 73.1 years
(54.0% men). Re-entry was successful in 34 attempts (64.5%). Causes of
failure included inability to re-enter the true lumen in 11 (61.1%), difficulty
tracking the device over a wire in 3 (16.7%), acute angle of aortic bifurcation
in 2 (11.1%), mechanical failure of the device in 1 (5.6%), and difficulty
tracking the device through the lesion in 1 (5.6%). Moderate or severe
calcification at the site of re-entry was the only significant predictor of failure
(odds ratio, 6.3; P  .01). An aortic bifurcation angle 40° did trend
toward predicting success (odds ratio, 0.23; P  .54).
Conclusions: Although re-entry devices can be successful in extending
the applicability of endovascular management to difficult femoropopliteal
occlusions, they are not uniformly successful in current clinical practice.
Significant calcification at the proposed re-entry site is a strong predictor of
failure.
Infrageniculate Interventions in Female Patients: Improved Patency
Rates but Higher Rates of Postoperative Complications
Tejas R. Shah, MD, Angeliki Vouyouka, MD, Daniel K. Han, BA, Sharif
Ellozy, MD, Robert Lookstein, MD, Prasad Shirvalkar, MS, Michael Marin,
MD, and Peter L. Faries, MD,Mount Sinai Medical Center, New York, NY,
USA
Introduction: Infrageniculate arterial disease is increasingly treated
with endovascular management as an alternative to open surgery. Although
previous studies have analyzed the effect of gender on the success of other
arterial interventions, little is known about outcomes of infrageniculate
interventions between men and women.
Methods: Infrageniculate interventions were retrospectively reviewed
in a prospectively maintained database from 1999 to 2009. Primary end
points included technical success, limb salvage, primary patency, and sec-
ondary patency rates. Secondary end points included access site complica-
tions (ie, hematoma, thrombosis) and systemic complications (ie, myocar-
dial infarction, death).Results: Between July 1999 and November 2009, 329 tibial lesions
were treated in 277 patients, comprising 152 men (mean age, 71.4  13.1
